Marked Improvement of Neuropsychiatric Symptoms Following Control of Allergy Symptoms With the Use of Humanized Murine Anti-IgE Antibody (Omalizumab) in 2 Patients With Severely Limited Expressive Language
Allergy, Asthma and Clinical Immunology - United Kingdom
doi 10.1186/s13223-015-0105-x
Full Text
Open PDFAbstract
Available in full text
Date
December 1, 2015
Authors
Publisher
Springer Science and Business Media LLC